WINDTREE THERAPEUTICS INC /DE/ - WINT

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2024 · Q3 2024
Value (USD)
Total reported value ($000)
$97K
QoQ value delta ($000)
-$290K (-74.94%)
Implied price effect (QoQ)
-85.86%
Shares
Total shares
288,937
QoQ shares delta
+125,891 (+77.21%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (WINT)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2024)

Top 25 only Full list
Early Q2 2025 data: only 5 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
RENAISSANCE TECHNOLOGIES LLC 41 119,266 0.0%
GEODE CAPITAL MANAGEMENT, LLC 20 59,167 0.0%
UBS Group AG 20 59,611 0.0%
XTX Topco Ltd 6 19,456 0.0%
TWO SIGMA INVESTMENTS, LP 5 14,449 0.0%
GOLDMAN SACHS GROUP INC 4 12,326 0.0%
Tower Research Capital LLC (TRC) 1 4,521 0.0%
BANK OF AMERICA CORP /DE/ 0 70 0.0%
WELLS FARGO & COMPANY/MN 0 1 0.0%
ROYAL BANK OF CANADA 0 2 0.0%
SBI Securities Co., Ltd. 0 62 0.0%
BlackRock, Inc. 0 6 0.0%